Remdesivir, the medicine used for treatment of COVID-19 infection, will be manufactured in Nepal.
This medicine will be produced in the country after the Department of Drug Administration (DDA) give permission for the same.
The DDA's information officer Santosh KC said the Birgunj-based National Health Care has been given permission for manufacturing the medicine. He added that permission has been given after observing all the infrastructures of the pharmaceutical company.
Until now, Remdesivir is being imported from India and Bangladesh. The medicine costs approximately Rs 5,000.
Vice President of National Health Care, Ajaya Pandey, has informed that they are preparing to bring raw materials for the medicine from China after getting the permission. According to him, the raw materials will be brought within May 31. The medicine will be produced in 15 days from that date and will be supplied to the market.
READ ALSO:
